0.562
price down icon7.90%   -0.0482
after-market 시간 외 거래: .60 0.038 +6.76%
loading
전일 마감가:
$0.6102
열려 있는:
$0.6
하루 거래량:
169.69K
Relative Volume:
1.52
시가총액:
$5.31M
수익:
$34.07M
순이익/손실:
$-20.13M
주가수익비율:
-0.0435
EPS:
-12.92
순현금흐름:
$-24.90M
1주 성능:
-12.16%
1개월 성능:
-23.00%
6개월 성능:
-37.56%
1년 성능:
-44.36%
1일 변동 폭
Value
$0.536
$0.61
1주일 범위
Value
$0.536
$0.658
52주 변동 폭
Value
$0.536
$2.22

Biofrontera Inc Stock (BFRI) Company Profile

Name
명칭
Biofrontera Inc
Name
전화
781-245-1325
Name
주소
120 PRESIDENTIAL WAY,, WOBURN
Name
직원
93
Name
트위터
Name
다음 수익 날짜
2024-11-13
Name
최신 SEC 제출 서류
Name
BFRI's Discussions on Twitter

BFRI을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
BFRI
Biofrontera Inc
0.562 6.04M 34.07M -20.13M -24.90M -12.92
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
11.35 50.14B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
168.63 72.38B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
RDHL
Redhill Biopharma Ltd Adr
1.79 4.22M 35.75M 11.57M -26.25M -3.8069
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.03 45.51B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.78 19.45B 16.54B -1.64B 749.00M -1.45

Biofrontera Inc 주식(BFRI)의 최신 뉴스

pulisher
May 30, 2025

Biofrontera stock hits 52-week low at $0.58 amid market challenges - Investing.com India

May 30, 2025
pulisher
May 27, 2025

Biofrontera AG Faces Financial Uncertainty Amid Biofrontera Inc. Payment Issues - TipRanks

May 27, 2025
pulisher
May 23, 2025

Biofrontera Receives Nasdaq Non-Compliance Notice - TipRanks

May 23, 2025
pulisher
May 22, 2025

Roth Capital Decreases Earnings Estimates for Biofrontera - Defense World

May 22, 2025
pulisher
May 22, 2025

Q2 Earnings Forecast for Biofrontera Issued By Roth Capital - Defense World

May 22, 2025
pulisher
May 20, 2025

Biofrontera Inc. (NASDAQ:BFRI) Q1 2025 Earnings Call Transcript - Insider Monkey

May 20, 2025
pulisher
May 20, 2025

Biofrontera (NASDAQ:BFRI) Price Target Lowered to $2.75 at Benchmark - Defense World

May 20, 2025
pulisher
May 19, 2025

Biofrontera, Inc. Earnings Call: Growth Amid Challenges - TipRanks

May 19, 2025
pulisher
May 19, 2025

Benchmark cuts Biofrontera stock target to $2.75, keeps Buy rating By Investing.com - Investing.com Nigeria

May 19, 2025
pulisher
May 19, 2025

Photodynamic Therapy Market Trends Report 2025-2033, Competitive Analysis of Gladerma, Sun Pharma, Biofrontera, Lumibird, Bausch Health, Soligenix, Modulight, and Theralase TechnologiesResearchAndMarkets.com - FinancialContent

May 19, 2025
pulisher
May 19, 2025

Biofrontera (BFRI) Sees Price Target Reduction by Benchmark | BF - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Benchmark cuts Biofrontera stock target to $2.75, keeps Buy rating - Investing.com Australia

May 19, 2025
pulisher
May 19, 2025

Biofrontera (BFRI) Target Price Trimmed After Lower Revenue Perf - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Biofrontera Inc. price target lowered to $2.75 from $7 at Benchmark - TipRanks

May 19, 2025
pulisher
May 19, 2025

Biofrontera signals 2025 record revenue ambitions with new Ameluz patent and cost controls - MSN

May 19, 2025
pulisher
May 17, 2025

Biofrontera Inc. (BFRI) Reports 9% Revenue Growth in Q1 2025 - GuruFocus

May 17, 2025
pulisher
May 16, 2025

Earnings call transcript: Biofrontera Q1 2025 sees revenue rise, stock dips - Investing.com Nigeria

May 16, 2025
pulisher
May 16, 2025

Earnings call transcript: Biofrontera Q1 2025 sees revenue rise, stock dips By Investing.com - Investing.com South Africa

May 16, 2025
pulisher
May 16, 2025

Transcript : Biofrontera Inc., Q1 2025 Earnings Call, May 16, 2025 - marketscreener.com

May 16, 2025
pulisher
May 16, 2025

BFRI Increases Q1 Revenue and Expands Market Presence | BFRI Sto - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Biofrontera extends Ameluz patent to 2043 for acne treatment By Investing.com - Investing.com Nigeria

May 16, 2025
pulisher
May 15, 2025

Biofrontera Inc. reports Q1 EPS (47c) vs. ($2.88) last year - TipRanks

May 15, 2025
pulisher
May 15, 2025

Biofrontera Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 15, 2025
pulisher
May 15, 2025

Biofrontera Inc. (BFRI) Sees Encouraging Revenue Growth in Q1 | - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Biofrontera Inc. (BFRI) Sees Encouraging Revenue Growth in Q1 | BFRI Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Biofrontera Inc. Reports First Quarter 2025 Financial Results and Provides a Business Update - The Manila Times

May 15, 2025
pulisher
May 15, 2025

Biofrontera Inc. reports Q1 EPS (47c) vs. (71c) last year - TipRanks

May 15, 2025
pulisher
May 15, 2025

Biofrontera (BFRI) Achieves Patent Approval and Advances Clinica - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Biofrontera Announces New Patent Protection On Ameluz Until 2043 - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Biofrontera (BFRI) Achieves Patent Approval and Advances Clinical Trials | BFRI Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Biofrontera's Revised Ameluz Formulation Receives US Patent Approval - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Biofrontera extends Ameluz patent to 2043 for acne treatment - Investing.com

May 15, 2025
pulisher
May 15, 2025

Biofrontera Inc. Announces New Patent Protection on Ameluz® until 2043 and the Completion of Patient Enrollment in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris - The Manila Times

May 15, 2025
pulisher
May 15, 2025

Biofrontera Inc. announces patent protection on Ameluz until 2043 - TipRanks

May 15, 2025
pulisher
May 15, 2025

Biofrontera Inc. faces Nasdaq delisting over share price By Investing.com - Investing.com Nigeria

May 15, 2025
pulisher
May 14, 2025

Biofrontera Inc. faces Nasdaq delisting over share price - Investing.com Australia

May 14, 2025
pulisher
May 14, 2025

Biofrontera Faces Nasdaq Non-Compliance Notice - TipRanks

May 14, 2025
pulisher
May 08, 2025

Biofrontera (BFRI) to Release Earnings on Thursday - Defense World

May 08, 2025
pulisher
May 06, 2025

Dermatology Leader Biofrontera Announces First Quarter 2025 Earnings Date: Key Details Inside - Stock Titan

May 06, 2025
pulisher
May 06, 2025

Biofrontera Inc. to Report First Quarter FY 2025 Financial Results on May 15, 2025 - ACCESS Newswire

May 06, 2025
pulisher
May 02, 2025

Biofrontera and Almirall Launch the Hats On Challenge to Raise Awareness and Support for Actinic Keratosis - GlobeNewswire

May 02, 2025
pulisher
May 01, 2025

Major Skin Cancer Prevention Campaign Launches as 58M Americans Face Actinic Keratosis Risk - Stock Titan

May 01, 2025
pulisher
Apr 29, 2025

Biofrontera Inc. Reports Third Quarter and Nine-Month 2024 Financial Results and Provides Business Update - ADVFN

Apr 29, 2025

Biofrontera Inc (BFRI) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
drug_manufacturers_specialty_generic RGC
$877.00
price up icon 18.36%
drug_manufacturers_specialty_generic HCM
$13.89
price up icon 0.22%
$123.02
price down icon 0.52%
drug_manufacturers_specialty_generic RDY
$14.72
price down icon 0.20%
$318.85
price down icon 0.47%
$16.78
price down icon 4.28%
자본화:     |  볼륨(24시간):